Once-daily topical treatment of mild / moderate alopecia areata (AA) with 1% STS-01 met the primary efficacy endpoint of >30% Severity of Alopecia Tool (SALT) score improvement compared to patients receiving placebo (p<0.0096) Multiple secondary endpoints met with significant total hair regrowth across the 1% and 2% dose groups STS-01 was well tolerated with no major adverse events STS-01 has the potential to become the first approved therapy and standard of care for mild / m

Stassets Investment Leads Round with Major Contribution, Joined by LSK Investment and Shinhan Capital Investment Provides Crucial Resources for Company's Focus on Developing Small Molecule Synthetic New Drugs in Synthetic Lethality, DNA Damage Response, and Cell Cycle Sectors First-In-Class AD1208 Preclinical Results Announced at AACR in April SEOUL, South Korea, May 29, 2024 /PRNewswire/ -- Avelos Therapeutics, a leading innovator in the development of novel anti-cancer drugs, recently co

Chi-Wan Lee, head of Samyang's research institute, presents research on the importance of adhesives for improving EV motor performance and the superiority of the company's products Eco-friendly adhesive utilizing Isosorbide shows superior adhesion, thermal stability, and oil resistance compared to conventional products Room temperature curing reduces costs and time, customizable for different types and uses of steel sheets SEOUL, South Korea, May 29, 2024 /PRNewswire/ -- Samya